Interleukin-6 induces VEGF secretion from prostate cancer cells in a manner independent of androgen receptor activation

Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels

(2015) Tomofumi Miura et al.   PANCREAS

Neuroendocrine differentiation in prostate cancer: Current and emerging therapy strategies

(2014) Vincenza Conteduca et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway

(2013) Mohammad Zahid Kamran et al.   BIOMEDICINE & PHARMACOTHERAPY

The role of intratumoral and systemic IL-6 in breast cancer

(2013) Christine Dethlefsen et al.   BREAST CANCER RESEARCH AND TREATMENT

Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy

(2012) Chin Hao Chang et al.   INTERNATIONAL JOURNAL OF CANCER

Low Androgen Sensitivity Is Associated With Low Levels of Akt Phosphorylation in LNCaP-E9 Cells

(2012) K. Iguchi et al.   JOURNAL OF ANDROLOGY

Characterization of the low pH/low nutrient-resistant LNCaP cell subline LNCaP-F10

(2012) KAZUHIRO IGUCHI et al.   ONCOLOGY REPORTS

Altered TGF-β Signaling in a Subpopulation of Human Stromal Cells Promotes Prostatic Carcinogenesis

(2011) Omar E. Franco et al.   CANCER RESEARCH

Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer

(2011) K. Fizazi et al.   EUROPEAN JOURNAL OF CANCER

Heterogenous induction of carcinoma-associated fibroblast-like differentiation in normal human prostatic fibroblasts by co-culturing with prostate cancer cells

(2011) Kenichiro Ishii et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Molecular States Underlying Androgen Receptor Activation: A Framework for Therapeutics Targeting Androgen Signaling in Prostate Cancer

(2011) Peter S. Nelson   JOURNAL OF CLINICAL ONCOLOGY

Manserin as a novel histochemical neuroendocrine marker in prostate cancer

(2011) Kouhei Nishikawa et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone

(2009) Atsushi Mizokami et al.   ENDOCRINE-RELATED CANCER

Evidence that androgen-independent stromal growth factor signals promote androgen-insensitive prostate cancer cell growth in vivo

(2009) Kenichiro Ishii et al.   ENDOCRINE-RELATED CANCER

Neuroendocrine differentiation in the progression of prostate cancer

(2009) Akira Komiya et al.   INTERNATIONAL JOURNAL OF UROLOGY